Shop
Year of Establishment: 1996
Total Number of Staff: more than 1000
Main Competitive Advantages: Brand Name,Experienced R&D Staff,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Amoytop Biotech, as a leading enterprise on exporting recombinant protein drugs in China, has passed GMP inspections from several countries' health authorities, including Pakistan, Brazil, and Russia, etc.
Patents and Copyrights: Two patents for the structure of Pegberon® - Patent of Y-shape branched PEG structure (Y-shape): International Application No.: PCT / CN/03/ 00179, International Publication Number: WO 03/076490; - Patent of structural site and preparation process: International Application No.: PCT / CN2007 / 002644, International Publication Number: WO 2009/030066; Covers 30 regions and countries, including China, America, Europe, Japan, Korea, Canada, Australia, Russia, S . Africa, etc. Expiry date of patent: 2027